NovAccess Global Inc.

NovAccess Global Inc., a biopharmaceutical company specializing in the development of novel immunotherapies for brain tumor patients, has recently released its 10-K filing for the fiscal year ended September 30, 2023. This blog post aims to provide a detailed review of the company's financial hea...